Centerline Biomedical, a Cleveland Clinic spinoff, is part of this Wall Street Journal story about tech advances that are making the operating room “smarter, more effective — and a lot less risky for patients.”
Preclinical study update: Jan 2, 2018 Endovascular navigation startup demonstrates use of navigation system Cleveland, Ohio: As Centerline Biomedical, Inc. prepares to meet with investors, strategic partners and companies in the…
We are proud to announce that Centerline Biomedical has been chosen as a MedTech Innovator Top 50 showcase company! The 50 companies were chosen from nearly 600 applicants to the 2017 MedTech Innovator competition.
We are proud to announce that, on March 29th, 2017, Centerline Biomedical, Inc. was approved by the Ohio Third Frontier Commission for a $1.26M Commercial Acceleration Loan Fund (CALF), under the Ohio Third Frontier Program, managed by the State of Ohio’s Development Services Agency (DSA).
Surgical navigation startup Centerline Biomedical, Inc. closed a Series A funding round in December 2016. This significant milestone comes on the heels of several preclinical studies and builds upon successful financing and outreach achieved over the course of 2016, driving the company forward in its commercialization mission.
Building on a study performed in May, Centerline Biomedical, Inc. successfully completed two additional preclinical studies evaluating its advanced surgical navigation system known as IOPS, the Intra-Operative Positioning System. The studies demonstrated the ability to track navigation of catheters and guidewires precisely, with enhanced 3-D visualization, and without the harmful effects associated with the current standard of care.
Centerline Biomedical, a Cleveland Clinic spinoff company, successfully completed its first preclinical study evaluating its innovative endovascular navigation technology, IOPS, at the world-renowned Lerner Research Institute on Monday, May 2nd.